Conmed (CNMD) Tops Q2 EPS by 27c ; Offers Guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $50.48 --0%
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q2 EPS of $1.38, $0.27 better than the analyst estimate of $1.11. Revenue for the quarter came in at $343.5 million versus the consensus estimate of $337.46 million.
GUIDANCE:
Conmed sees FY2026 EPS of $4.48-$4.60, versus the consensus of $4.34. Conmed sees FY2026 revenue of $1.36-1.37 billion, versus the consensus of $1.36 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollar Tree (DLTR) Tops Q2 EPS by $1.59, Beats on Revenue; Offers FY Guidance
- BofA Securities Upgrades Sun Communities (SUI) to Neutral
- Bernstein SocGen Group Reiterates Market Perform Rating on Bloom Energy Corp. (BE)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
